🔎 Trials Near Me

Hjem › Multipel sklerose › New Jersey

Multipel sklerose kliniske forsøg i New Jersey

11 studier for Multipel sklerose søger deltagere på steder i New Jersey.

Byer i New Jersey

Officiel studietekst (engelsk)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Rutgers Cancer Institute of New Jersey, New Brunswick
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Bridgewater
  • TG Therapeutics Investigational Trial Site, Cherry Hill
  • TG Therapeutics Investigational Trial Site, Freehold
  • og 3 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06433752

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Holy Name Medical Center- Site Number : 8400101, Teaneck
RekruttererFase 3
Alder 18 til 60 · Alle køn · Opdateret 15. sep. 2026 · NCT07325292

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • Local Institution - 0131, New Brunswick
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 10. sep. 2026 · NCT06408259

A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

  • Novartis, East Hanover
RekruttererObservationsstudie
Alder 18 til 100 · Alle køn · Opdateret 21. aug. 2026 · NCT07779460

A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

  • Kessler Foundation, East Hanover
Rekrutterer
Alder 18 til 70 · Alle køn · Opdateret 5. aug. 2026 · NCT06197685

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

  • Bristol Myers Squibb, Lawrenceville
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 29. jul. 2026 · NCT07732907

Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

  • Atlantic Health, Morristown
RekruttererFase 4
Alder 18 og opefter · Kvinder · Opdateret 29. maj 2026 · NCT07614321

Multiple Sclerosis Implementation Network (Registry)

  • Multiple Sclerosis Association of America, Cherry Hill
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT07415824

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

  • Kessler Foundation, West Orange
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 24. nov. 2025 · NCT04855825

Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community

  • Kessler Foundation, East Hanover
Rekrutterer
Alder 19 til 65 · Alle køn · Opdateret 21. feb. 2025 · NCT06608797

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.